Cabaletta Bio, Inc.
CABA
$2.75
$0.041.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.19% | -14.47% | -22.25% | 0.12% | 20.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.32% | 19.28% | 26.12% | 40.98% | 51.61% |
| Operating Income | -13.32% | -19.28% | -26.12% | -40.98% | -51.61% |
| Income Before Tax | -13.05% | -21.07% | -28.64% | -46.48% | -63.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.05% | -21.07% | -28.64% | -46.48% | -63.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.05% | -21.07% | -28.64% | -46.48% | -63.50% |
| EBIT | -13.32% | -19.28% | -26.12% | -40.98% | -51.61% |
| EBITDA | -13.67% | -19.94% | -26.85% | -41.75% | -52.21% |
| EPS Basic | 53.72% | 45.16% | 38.46% | 29.14% | -30.65% |
| Normalized Basic EPS | 53.73% | 45.15% | 38.47% | 29.15% | -30.64% |
| EPS Diluted | 53.72% | 45.16% | 38.46% | 29.24% | -30.23% |
| Normalized Diluted EPS | 53.73% | 45.15% | 38.47% | 29.15% | -30.64% |
| Average Basic Shares Outstanding | 144.29% | 120.77% | 109.04% | 106.71% | 25.14% |
| Average Diluted Shares Outstanding | 144.29% | 120.77% | 109.04% | 106.71% | 25.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |